Literature DB >> 23284068

C9ORF72 hexanucleotide expansions of 20-22 repeats are associated with frontotemporal deterioration.

Estrella Gómez-Tortosa1, Jesús Gallego, Rosa Guerrero-López, Alberto Marcos, Eulogio Gil-Neciga, María José Sainz, Asunción Díaz, Emilio Franco-Macías, María José Trujillo-Tiebas, Carmen Ayuso, Julián Pérez-Pérez.   

Abstract

OBJECTIVE: Expansions of more than 30 hexanucleotide repetitions in the C9ORF72 gene are a common cause of frontotemporal dementia (FTD) or amyotrophic lateral sclerosis (ALS). However, the range of 20-30 repetitions is rarely found and still has unclear significance. A screening of our cohort of cases with FTD (n = 109) revealed 4 mutation carriers (>30 repetitions) but also 5 probands with 20-22 confirmed repetitions. This study explored the possible pathogenic correlation of the 20-22 repeats expansion (short expansion).
METHODS: Comparison of clinical phenotypes between cases with long vs short expansions; search for segregation in the families of probands with short expansion; analysis of the presence of the common founder haplotype, described for expansions >30 repeats, in the cases having the short expansion; and analysis of the distribution of hexanucleotide repeat alleles in a control population.
RESULTS: No different patterns were found in the clinical phenotype or aggressiveness of the disease when comparing cases with long or short expansions. Cases in both groups had psychiatric symptoms during 1-3 decades before evolving insidiously to cognitive deterioration. The study of the families with short expansion showed clear segregation of the 20-22 repeats allele with the disease. Moreover, this 20-22 repeats allele was associated in all cases with the pathogenic founder haplotype. None of 216 controls had alleles with more than 14 repetitions.
CONCLUSIONS: Description of these families suggests that short C9ORF72 hexanucleotide expansions are also related to frontotemporal cognitive deterioration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23284068     DOI: 10.1212/WNL.0b013e31827f08ea

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  32 in total

1.  Frontotemporal dementia with a C9ORF72 expansion in a Swedish family: clinical and neuropathological characteristics.

Authors:  Maria Landqvist Waldö; Lars Gustafson; Karin Nilsson; Bryan J Traynor; Alan E Renton; Elisabet Englund; Ulla Passant
Journal:  Am J Neurodegener Dis       Date:  2013-11-29

Review 2.  The Genetics of C9orf72 Expansions.

Authors:  Ilse Gijselinck; Marc Cruts; Christine Van Broeckhoven
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

3.  The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures.

Authors:  Kaalak Reddy; Bita Zamiri; Sabrina Y R Stanley; Robert B Macgregor; Christopher E Pearson
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

4.  Validation of a Long-Read PCR Assay for Sensitive Detection and Sizing of C9orf72 Hexanucleotide Repeat Expansions.

Authors:  EunRan Suh; Kaitlyn Grando; Vivianna M Van Deerlin
Journal:  J Mol Diagn       Date:  2018-08-20       Impact factor: 5.568

5.  C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis.

Authors:  Micaela Fredi; Ilaria Cavazzana; Giorgio Biasiotto; Massimiliano Filosto; Alessandro Padovani; Eugenio Monti; Angela Tincani; Franco Franceschini; Isabella Zanella
Journal:  Neuromolecular Med       Date:  2019-03-11       Impact factor: 3.843

Review 6.  Alzheimer's Disease and Frontotemporal Dementia: The Current State of Genetics and Genetic Testing Since the Advent of Next-Generation Sequencing.

Authors:  Jill S Goldman; Vivianna M Van Deerlin
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

Review 7.  Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.

Authors:  Xinmei Wen; Thomas Westergard; Piera Pasinelli; Davide Trotti
Journal:  Neurosci Lett       Date:  2016-09-13       Impact factor: 3.046

Review 8.  C9ORF72 mutations in neurodegenerative diseases.

Authors:  Ying Liu; Jin-Tai Yu; Yu Zong; Jing Zhou; Lan Tan
Journal:  Mol Neurobiol       Date:  2013-08-10       Impact factor: 5.590

Review 9.  ALS: Recent Developments from Genetics Studies.

Authors:  Martine Therrien; Patrick A Dion; Guy A Rouleau
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

10.  Early Cognitive, Structural, and Microstructural Changes in Presymptomatic C9orf72 Carriers Younger Than 40 Years.

Authors:  Anne Bertrand; Junhao Wen; Daisy Rinaldi; Marion Houot; Sabrina Sayah; Agnès Camuzat; Clémence Fournier; Sabrina Fontanella; Alexandre Routier; Philippe Couratier; Florence Pasquier; Marie-Odile Habert; Didier Hannequin; Olivier Martinaud; Paola Caroppo; Richard Levy; Bruno Dubois; Alexis Brice; Stanley Durrleman; Olivier Colliot; Isabelle Le Ber
Journal:  JAMA Neurol       Date:  2018-02-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.